Articles about University of Oxford

The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.

After the first day of the massive coronavirus vaccination drive in India led to disappointing results — the target of inoculating three lakh healthcare workers wasn't met — the country picked pace and 10,43,534 people have now been given the first dose of either Covishield or COVAXIN, data from Health Ministry revealed.

In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

England's 56 million people were ordered to stay at home by Prime Minister Boris Johnson on Monday, as the United Kingdom struggles to contain a new variant of coronavirus.

A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.

India recorded less than 300 deaths linked to coronavirus every day between last Thursday and today, the government said.

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.

Though India is yet to approve a coronavirus vaccine candidate, on December 28 and 29, the Centre has planned a dry run in four states to judge the preparedness of the vaccination program, PTI reported on Friday.

From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.

The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.

The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.

Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said.

Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

The coronavirus vaccine being developed by Bharat Biotech could be launched by February, months earlier than expected, an official from the Indian Council of Medical Research (ICMR), told Reuters on Thursday.

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.

In a bid to exit the COVID-19 pandemic for good, Australia has secured access to a "promising vaccine."

Since the coronavirus outbreak started late last year, researchers have been racing to develop a vaccine against the virus, SARS-CoV-2.

COVID-19 has wreaked havoc around the world, leaving everyone desperate for a vaccine - a much-needed shot that prevents contraction or at least mitigates the severe impact of the novel coronavirus.

As the race to develop vaccines and anti-viral treatments for COVID-19 continues, researchers in the UK have confirmed that Dexamethasone, an existing and pretty affordable drug, can prove 'life-saving' for critical cases of the disease.

Healthcare workers in the United Kingdom will begin taking hydroxychloroquine on Thursday as part of a trial to test the drug's efficacy in preventing COVID-19.

Despite there existing thousands of cultures around the world, anthropologists from the University of Oxford have identified seven 'universal' moral rules that are present across human cultures.

IISc-Bangalore has been ranked among the top 100 universities in the world in the subject category 'Engineering and Technology' in 2019 Times Higher Education rankings.

According to the Times Higher Education (THE) World University Rankings 2019, published Wednesday, India saw a record 49 universities being chosen among the world's best.

Two Indian teachers bagged a two-week classroom course at the University of Oxford by topping CENTA Teaching Professionals' Olympiad (TPO).

Yashveer Singh, Director of Ashoka Innovators for the Public's youth program has been invited to speak at London School of Economics and Political Science's India Forum for its annual conference, LSE SU India Forum (LIF) 2018.

Indian-origin scientist Pratibha Gai has been appointed a Dame (female equivalent for a knight) for her services to chemical sciences and technology, as per the Queen's New Year's Honours List 2018, that was released on Saturday.

Google has claimed that its AlphaGo Zero artificial intelligence (AI) program has defeated Stockfish 8, the world's leading specialist software, in chess.

UK-based online retailer Ocado Technologies is looking to get driverless vehicles on the road to deliver groceries to their customers, reports said.